Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer

Giuseppe Gattuso(University of Catania), Luca Falzone(University of Catania), Lucia Salvatorelli(University of Catania), Alessandro Lavoro(University of Catania), Graziana Spoto(University of Catania), Antonio Di Cataldo(University of Catania), Daria Ricci(University of Catania), Giuseppe Broggi(University of Catania), Federica Longo(University of Catania), Gaetano Magro(University of Catania), Saverio Candido(University of Catania), Massimo Libra(University of Catania)
International Journal of Molecular Sciences
January 30, 2025
10.3390/ijms26031219
Cited by 5

Related Papers

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
|Oncotarget|2012|317